TriSalus Life Sciences Inc. logo

TriSalus Life Sciences Inc.

TLSI | NASDAQ
Chart Builder DCF Calculator
$4.98
-$0.12 (-2.35%)
At close: Sep 21, 2026, 4:00 PM ET
$5.07
+$0.09 (+1.81%)
After-hours: Sep 21, 2026, 4:13 PM ET

Market Data

Market Cap
$306.64M
Enterprise Value
$294.78M
Beta
0.44
Average Volume
390.29K
Shares Outstanding (Diluted)
58.3M
Shares Change YoY
77.2%
Institutional Ownership
40.46%
Exchange
NASDAQ
ISIN
US89680M1018

Price Performance

Price Change 1M
-3.7%
Price Change 3M
23.6%
Price Change 6M
24.2%
Price Change YTD
-18.4%
Price Change 1Y
2.0%
Price Change 3Y
-9.4%
Price Change 5Y
-49.9%
1M CAGR (ann.)
-11.2%
1Y CAGR (ann.)
1.2%
5Y CAGR (ann.)
-12.8%
All-Time CAGR
-12.5%

Valuation

PE Ratio
-3.83
Forward PE
83.33
PEG Ratio
0.07
Forward PEG
0.20
PS Ratio
6.80
Forward PS
4.10
PB Ratio
46.82
P/FCF Ratio
-10.25
P/Adj. FCF Ratio
-7.12
P/OCF Ratio
-9.96
EV/Sales
6.54
EV/EBIT
-13.18
EV/EBITDA
-13.61
EV/FCF
-9.86
Earnings Yield
-26.1%
FCF Yield
-9.8%
Adj. FCF Yield
-14.1%

Financial Health

Net Cash
$11.86M
Total Debt
$34.43M
Cash & Short-Term Investments
$46.29M
Total Assets
$62.45M
Current Ratio
5.35
Quick Ratio
4.97
Debt / Equity Ratio
5.26
Debt / EBITDA
-1.59
Debt / FCF
-1.15
OCF / Debt
-0.85
Interest Coverage
-5.23
Altman Z-Score
-3.82
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
85.8%
Operating Profit Margin
-67.7%
EBITDA Margin
-48.1%
Net Profit Margin
-62.6%
FCF Margin
-66.3%
Adj. FCF Margin
-95.6%
SBC / Revenue
29.2%
SBC Impact (per share)
-44.1%

Returns

Return on Assets
-45.2%
Return on Equity
273.7%
Return on Invested Capital
-59.2%
Return on Capital Employed
-59.5%
Return on Tangible Assets
-45.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
45.1%
Revenue CAGR 5Y
37.3%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
28.8%
EPS CAGR 5Y
-14.4%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
33.8%
FCF CAGR 5Y
0.9%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
3
EPS Growth Next 3Y
45.9%
Revenue Growth Next 3Y
46.4%
Earnings Date
Nov 11, 2026
EPS Estimate (next Q)
-$0.12
EPS Growth Est (next Q)
-87.5%
Revenue Est (next Q)
$14.31M
Revenue Growth Est (next Q)
23.8%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$9.50
Price Target Upside
90.8%

Cash Flow

Operating Cash Flow
$-29.28M
Free Cash Flow
$-29.9M
Adj. Free Cash Flow
$-43.08M
FCF Per Share
-$0.51
OCF Per Share
-$0.50
OCF/S Ratio
-65.0%

Income Statement

Revenue
$45.08M
Gross Profit
$38.67M
Operating Income
$-30.51M
EBITDA
$-21.67M
Net Income
$-28.21M
EPS (Diluted)
-$1.30
Revenue / Employee
$441.93K
Profit / Employee
$-276.59K
Employees
102

© 2026 bestshares.com. All rights reserved.